drug
rosuvastatin calcium
Marketedupdated 3mo agoby Teva Pharmaceuticals USA Inc
Approvedcommunity read0 votes
indications
investigational
Hyperlipidemia
all catalysts(0)
nothing on the calendar yet
Trials studying rosuvastatin calcium
- phase1Pharmacokinetic Effect of Y-3 for Injection on Rosuvastatin Calcium Tablets in Healthy Participants
- phase1A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects
- phase1A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects
- phase1Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects
- phase1Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
- phase3Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
- phase1To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in Volunteers
- phase1A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 12, 2036
~9.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Feb 12, 2036formulationUS 10413543
- Feb 12, 2036formulationUS 10413543
- Feb 12, 2036formulationUS 10413543
- Feb 12, 2036formulationUS 10413543
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that